In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1856 News Items found
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
detail shot of a microscope in an MSK lab
MSK Research Highlights, February 12, 2024

New research from MSK investigates overcoming drug resistance in chronic lymphocytic leukemia; describes a new method for identifying driver mutations in tumor samples; identifies a protein that orchestrates macrophages’ cancer-fighting abilities; and uncovers how cancer programs could do more to help patients quit smoking.
MSK physician-scientist Alex Kentsis
Epigenetic Combination Therapy Could Overcome Treatment Resistance in Epithelioid Sarcomas and Rhabdoid Tumors

Learn about a possible new treatment approach for soft tissue sarcomas.
An immunofluorescence image of an aged mouse liver.
CAR T Cells Show Promise Against Age-Related Diseases in Mice

Laboratory research led by MSK and Cold Spring Harbor Laboratory demonstrates the potential for CAR T cells to improve “healthspan” by eliminating senescent cells associated with aging-related diseases.
Human pluripotent stem cell-derived neurons
MSK Researchers Hack Neurons’ Internal Clocks To Accelerate the Study of Neurological Diseases

New research led by MSK has uncovered a way to “hack” neurons' internal clocks to speed up their development. The approach promises to accelerate research into neurological disease.
Detail shot of an MSK scientist in the lab
MSK Research Highlights, January 29, 2024

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.
Eric Lai playing guitar
Beyond the Bench: Developmental Biologist Eric Lai

How developmental biologist Eric Lai’s approach to science co-evolved with his music, art, and life outside the lab.
MSK nurse Margaret Bediones
MSK Nurse Dedicated To Serving the Underserved

Learn how Memorial Sloan Kettering Cancer Center nurse Margaret Bediones improves the health of underserved communities at the MSK Ralph Lauren Center in Harlem through community outreach focused on cancer prevention and screening.
Ingrid Adams speaks with nurse practitioner Virginia Ferreira.
In the Clinic
FDA Approves New Drug for Non-Small Cell Lung Cancer With ROS1 Fusions

Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types.
Looking through a microscope at a tissue sample
MSK Research Highlights, December 29, 2023

New MSK research developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell fate; and found an immunotherapy technique using antibodies that target CD47 shows promise in mice.